Transport, export and import of biological substances that contain or consist of pathogenic or genetically modified organisms - The transport pages provide practical instructions for the transport, import and export of biological substances. These instructions are based on the national and international (transport) regulations.

Pathogenic and genetically modified organisms in contained systems - If work is done with genetically modified or pathogenic organisms in laboratories, production facilities, culture rooms, greenhouses or other contained systems, measures must be taken to protect humans and the environment. These measures are stipulated by the Containment Ordinance and the Ordinance on Occupational Safety in Biotechnology. 

Experimental releases of genetically modified organisms - Experimental releases of genetically modified organisms require federal authorisation. The requirements are laid down in the Release Ordinance. Applications for the release of organisms are submitted to the SECB for its opinion and assessment of possible risks to humans and the environment. 

Placing genetically modified or pathogenic organisms on the market - According to the Release Ordinance the sale, exchange, import, release or marketing of genetically modified or pathogenic organisms is, subject to federal authorisation. The SECB issues Statements on applications for placing genetically modified or pathogenic organisms on the market, and assesses any impacts on the environment.

Gene therapy - In gene therapy, specific genes are inserted into the cells of an individual to try to cure diseases. Gene therapeutic intervention distinguishes between intervention in body or somatic cells. Clinical trials of somatic cell therapy have been conducted in Switzerland since 1994, subject to authorisation.